Key details
Sponsor
Prim. Prof. Dr. Oliver Findl, MBA
Enrollment target
~60 participants
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
21 Years – 105 Years
Last updated October 2024